Biological consistency and molecular heterogeneity in synchronous endometrial and ovarian carcinomas: a clinicopathological study within the FIGO 2023 framework
Paired molecular profiling (p53 and MMR) highlights the value of assessing tumor heterogeneity and clonal evolution for refined risk stratification and suggests clinical management may benefit from integrating molecular risk features to better distinguish true concordant SEOC from independent aggressive malignancies.